ESOPAug 7, 2026, 04:07 PM
Vera Therapeutics Grants Inducement Awards to New CRO & Staff
AI Summary
Vera Therapeutics granted inducement awards to its new Chief Regulatory Officer, Nancy Bowman, and two other new employees. These awards, approved by the Compensation Committee, include non-qualified stock options and restricted stock units (RSUs) under the 2024 Inducement Plan. The awards are designed to attract and retain talent, with specific vesting schedules over four years.
Key Highlights
- Inducement awards granted to new Chief Regulatory Officer, Nancy Bowman.
- Awards also granted to two additional new employees.
- CRO received 63,011 stock options and 44,987 RSUs.
- Two employees received 5,600 stock options and 2,800 RSUs.
- CRO's stock options exercise price: $32.23.
- Other employees' stock options exercise price: $29.95.
- Stock options and RSUs vest over four years.
- Awards approved under Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from VERA